In this webinar, experts will provide different perspectives on the role of primary care and other sectors as the distribution of the vaccines against COVID-19 ramps up.
23 Feb 2021
A monoclonal antibody combination was effective for postexposure prophylaxis and received emergency use authorization. A study investigated postvaccine myocarditis and pericarditis, and effects of full-dose anticoagulation differed by whether patients were critically ill.
10 Aug 2021
Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
15 Jun 2021
Several groups in the U.S. are now eligible to receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine at least six months after completing the initial two-dose series.
28 Sep 2021
Several COVID-19 studies looked at persistent symptoms, while new vaccine research found limited antibody responses in some patients and advised on tests for clotting complications. Other studies quantified the target population for tocilizumab treatment and gender differences in infections.
25 May 2021
New studies looked at the safety of the adenovirus COVID-19 vaccines, the effectiveness of almost all the vaccines, and the impacts of COVID-19 infection in pregnancy and on long-term cardiac function. A physician columnist addressed pandemic-related anger.
11 May 2021
An industry-funded study found benefit with bamlanivimab plus etesevimab for high-risk ambulatory COVID-19 patients, the FDA noted a possible increased risk for Guillain-Barré syndrome with the Johnson & Johnson (Janssen) vaccine, and two studies looked at COVID-19 messaging for minority populations.
20 Jul 2021
Bamlanivimab reduced viral load in mild to moderate cases when combined with etesevimab, new vaccine recommendations, research, and educational resources were released, and two studies provided longer-term data on patients who had COVID-19.
26 Jan 2021
Recent COVID-19 vaccine studies showed good response in pregnant women, as well as possible localized rashes from the Moderna vaccine. Analyses of ICU patients and those treated at a post-COVID-19 clinic highlighted the long-term effects of the virus, and a study found that dialysis patients maintained antibodies six months after COVID-19 infection.
18 May 2021
A modeling study examined four scenarios for extended vaccination in women and men up to ages 26, 30, 40, and 45 years.
10 Dec 2019